麻豆国产原创视频

Statement on Essure devices in New Zealand

RANZCOG calls for support for New Zealand women who have concerns about Essure contraceptive devices.

RANZCOG

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Updated
20 May 2024
SHARE

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) has written to asking that women with Essure contraceptive devices have access to information, advice and care to address any concerns they have that may be related to the device.

The permanent contraceptive device Essure was intended to provide permanent contraception and an alternative to other permanent contraception procedures such as tubal ligation or hysterectomy.

Essure was withdrawn from the market in New Zealand and subject to a recall of unused devices in 2017. A small number of women have experienced issues with device functioning or side effects. Medsafe say that they received 11 reports of adverse events associated with Essure.
Reports included changes in menstrual bleeding, unintended pregnancy, chronic pain, perforation and migration of the device, allergy/hypersensitivity, or immune-type reactions. Some of these reports were considered serious and resulted in removal of the device, which involved abdominal surgery.

There is no new evidence on effectiveness or issues associated with Essure, except that a small number of women may have had symptoms caused by the nickel content of the device. Nickel is routinely used in a number of medical devices including stents and artificial joints, but individuals with sensitivities can react to it.

Most women who have an Essure device will not experience issues and the device does not need to be removed if it is not causing issues.

Our key message for women is if you have an Essure device and you are concerned, or experiencing symptoms that may be related to the device, please discuss this with your GP or contact your local .

For media enquiries
Catherine Cooper
Executive Director, Aotearoa New Zealand and Global Health
ccooper@ranzcog.org.nz

CATEGORIES
Aotearoa New Zealand Statements and guidelines Women’s health

LATEST NEWS

Advocacy 31 May 2024
Now More Than Ever: National Reconciliation Week 2024
National Reconciliation Week (NRW) is a crucial time in Australia…
Advocacy 31 May 2024
Insights from the Aotearoa New Zealand Budget 2024
The Aotearoa New Zealand Government has released its 2024-2025 budget.
Advocacy 30 May 2024
RANZCOG Welcomes Opportunities to Improve Birthing Outcomes for Women
The College welcomes the report of the New South Wales…
Aotearoa New Zealand 20 May 2024
Dr John Tait Conferred as New President of AOFOG
Dr John Tait ONZM becomes first Aotearoa New Zealand President…
Advocacy 20 May 2024
RANZCOG Challenges Queensland Abortion Bill Amendment
The College has made a submission opposing the Queensland 鈥楾ermination…
Advocacy 14 May 2024
The Federal Budget: What It Means for Women鈥檚 Health
RANZCOG has summarised how the 2024-25 Australian federal budget allocations…
Advocacy 9 May 2024
New MBS Items a Win for Women’s Health
RANZCOG welcomes the addition of new MBS items which will…